文献速递骨质疏松与钙磷/甲状旁腺

携带杂合胚系CDC73突变甲状旁腺腺瘤与癌的比较基因组分析

A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

对12例携带胚系CDC73突变的甲状旁腺肿瘤(6例腺瘤、6例癌)及配对正常组织进行全外显子组和RNA测序,发现全部肿瘤均获得使第二个CDC73等位基因完全失活的体细胞事件;与腺瘤相比,甲状旁腺癌具有更多C>G颠换、APOBEC去氨化特征、PI-3K/mTOR通路基因突变、拷贝数变异及表达改变基因,但两者共享T细胞受体信号和肿瘤抗原呈递相关基因的复发突变与拷贝数缺失。

要点

  • 所有12例携带胚系CDC73突变的甲状旁腺肿瘤均存在第二个CDC73等位基因失活的体细胞事件。
  • 甲状旁腺癌比腺瘤有更多C>G颠换、APOBEC特征、PI-3K/mTOR通路突变及拷贝数变异。
  • 腺瘤与癌共享T细胞受体信号和抗原呈递基因的复发突变与拷贝数缺失。

核心结论

  • 携带胚系CDC73突变者发生甲状旁腺肿瘤需要双等位基因CDC73失活。
  • 甲状旁腺癌虽与腺瘤共享部分基因组特征,但具有更多独特改变,其中一些可能对癌形成至关重要。

研究设计与样本

  • 对12例携带胚系CDC73突变的甲状旁腺肿瘤(6例腺瘤和6例癌)及配对正常组织进行全外显子组和RNA测序。

主要发现

  • 全部12例甲状旁腺肿瘤均获得1个体细胞事件,预测导致第二个CDC73等位基因完全失活。
  • 与腺瘤相比,甲状旁腺癌具有更多携带C>G颠换的单核苷酸变异和APOBEC去氨化特征。
  • 甲状旁腺癌频繁发生PI-3K/mTOR信号通路相关基因突变,拷贝数变异数量更多,表达改变基因数量显著更多。
  • 腺瘤与癌均存在影响T细胞受体信号和肿瘤抗原呈递相关基因的复发体细胞突变和拷贝数缺失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Parathyroid cancer has been linked to germline mutations of the Cell Division Cycle 73 (CDC73) gene. However, carriers harboring cancer-associated germline CDC73 mutations may develop only parathyroid adenoma or no parathyroid disease. This incomplete penetrance indicates that additional genomic events are required for parathyroid tumorigenesis. OBJECTIVE: (1) Determine the status of the second CDC73 allele in parathyroid tumors harboring germline CDC73 mutations and (2) compare the genomic landscapes between parathyroid carcinomas and adenomas. DESIGN: Whole-exome and RNA sequencing of 12 parathyroid tumors harboring germline CDC73 mutations (6 adenomas and 6 carcinomas) and their matched normal tissues. RESULTS: All 12 parathyroid tumors had gained 1 somatic event predicted to cause a complete inactivation of the second CDC73 allele. Several distinctive genomic features were identified in parathyroid carcinomas compared to adenomas, including more single nucleotide variants bearing the C > G transversion and APOBEC deamination signatures, frequent mutations of the genes involved in the PI-3K/mTOR signaling, a greater number of copy number variations, and substantially more genes with altered expression. Parathyroid carcinomas also share some genomic features with adenomas. For instance, both have recurrent somatic mutations and copy number loss that impact the genes involved in T-cell receptor signaling and tumor antigen presentation, suggesting a shared strategy to evade immune surveillance. CONCLUSION: Biallelic inactivation of CDC73 is essential for parathyroid tumorigenesis in carriers harboring germline mutations of this gene. Despite sharing some genomic features with adenomas, parathyroid carcinomas have more distinctive alterations in the genome, some of which may be critical for cancer formation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li Y, Simonds WF, Chen H, et al. A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. J Clin Endocrinol Metab. 2025. PMID: 39044678. doi:10.1210/clinem/dgae506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。